Carvana executive Taira logs planned sale of 1,174 Class A shares

Carvana Co. executive Thomas Taira reported a small planned stock sale.

Rhea-AI Filing Summary

Carvana Co. executive Thomas Taira reported a small planned stock sale. On January 8, 2026, he sold 1,174 shares of Carvana Class A common stock at $447 per share in an open-market transaction. After this sale, he continued to beneficially own 68,252 shares, held directly.

The transaction was executed under a Rule 10b5-1 trading plan that Taira adopted on August 8, 2025, indicating the sale occurred pursuant to a pre-established plan rather than a discretionary trade at the time of sale.

Insider Trade Summary

Net Seller: 1,174 shares

Net Sell 1 txn

Insider Taira Thomas

Role President, Special Projects

Sold 1,174 shs ($525K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	1,174	$447.00	$525K

Holdings After Transaction: Class A Common Stock — 68,252 shares (Direct)

Footnotes (1)

1. F1. The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025.

FAQ

Who reported an insider transaction in Carvana (CVNA) and what is their role?

The reporting person is Thomas Taira, who serves as President, Special Projects at Carvana Co..

What type of Carvana (CVNA) security was involved in this insider transaction?

The transaction involved Carvana Class A common stock.

How many Carvana (CVNA) shares did Thomas Taira sell and at what price?

On January 8, 2026, Thomas Taira sold 1,174 shares of Carvana Class A common stock at a price of $447 per share.

How many Carvana (CVNA) shares does Thomas Taira own after the reported sale?

Following the reported transaction, Thomas Taira beneficially owned 68,252 shares of Carvana Class A common stock, held directly.

Was the Carvana (CVNA) insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing states that the sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.

Is this Carvana (CVNA) insider filing for one reporting person or a group?

The document shows the Form was filed by one reporting person, not by a group.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/09/2026 - 06:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taira Thomas

(Last) (First) (Middle)

300 E. RIO SALADO PKWY

(Street)

TEMPE AZ 85281

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CARVANA CO. [ CVNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Special Projects

3. Date of Earliest Transaction (Month/Day/Year)
01/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/08/2026		S		1,174(1)	D	$447	68,252	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025.

Remarks:

	/s/ Paul Breaux, by Power of Attorney for Thomas Taira	01/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.